Testing effectiveness (Phase 2)Study completedNCT00508924
What this trial is testing
Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)
Who this might be right for
Coronary Artery DiseaseAngina, Unstable
Tanabe Pharma Corporation 140